Holen Sie sich die Stockscreener-App
4.59
1.71%
-0.08
Vorhandelsmarkt:
4.59
Schlusskurs vom Vortag:
$4.67
Offen:
$4.67
24-Stunden-Volumen:
532.72K
Relative Volume:
0.71
Marktkapitalisierung:
$254.60M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
7.0615
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
-4.57%
1M Leistung:
-5.56%
6M Leistung:
+26.10%
1J Leistung:
-34.43%
1-Tages-Spanne:
$4.445
$4.68
1-Wochen-Bereich:
$4.40
$4.84
52-Wochen-Spanne:
$2.645
$7.4436
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Firmenname
Voyager Therapeutics Inc
Sektor
Branche
Telefon
857-259-5340
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Vergleichen Sie VYGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.59 | 259.04M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Eingeleitet | Citigroup | Buy |
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-10-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-26 | Eingeleitet | Guggenheim | Buy |
| 2024-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-07 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Eingeleitet | Truist | Buy |
| 2023-03-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-02-03 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-24 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-09-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-02-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-11-28 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-23 | Bestätigt | Stifel | Buy |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-28 | Fortgesetzt | Stifel | Buy |
Alle ansehen
Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten
Key resistance and support levels for Voyager Therapeutics Inc.Bull Run & Risk Managed Trade Strategies - newser.com
Can Voyager Therapeutics Inc. stock hit record highs againJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Sentiment analysis tools applied to Voyager Therapeutics Inc.Earnings Overview Report & Precise Buy Zone Tips - newser.com
Is Voyager Therapeutics Inc. stock a buy in volatile marketsWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Using R and stats models for Voyager Therapeutics Inc. forecasting2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
Developing predictive dashboards with Voyager Therapeutics Inc. dataJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Using portfolio simulators with Voyager Therapeutics Inc. included2025 Dividend Review & Weekly Market Pulse Updates - newser.com
Has Voyager Therapeutics Inc. formed a bullish divergenceEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Is Voyager Therapeutics Inc. a candidate for recovery playJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Multi asset correlation models including Voyager Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - newser.com
How high can Voyager Therapeutics Inc. stock goMarket Trend Review & Advanced Swing Trade Entry Alerts - newser.com
What drives Voyager Therapeutics Inc stock priceConsumer Goods Stocks & Free Daily Market Summary and Trend Reports - earlytimes.in
How institutional ownership impacts Voyager Therapeutics Inc. stock2025 Price Targets & Capital Protection Trade Alerts - newser.com
Is Voyager Therapeutics Inc. stock attractive after correctionEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Voyager Therapeutics Advances Alzheimer’s Study with VY7523 - MSN
Voyager Therapeutics Stock Lost 5.1%, Buy Or Wait? - Trefis
Owning 44% shares,institutional owners seem interested in Voyager Therapeutics, Inc. (NASDAQ:VYGR), - Yahoo Finance
Can Voyager Therapeutics Inc. stock hit analyst price targetsProduct Launch & Safe Entry Momentum Tips - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock compares to market leadersJuly 2025 Decliners & AI Driven Price Forecasts - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock benefits from tech adoption2025 Price Targets & Free Community Supported Trade Ideas - Fundação Cultural do Pará
How to recover losses in Voyager Therapeutics Inc. stockJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):